-
1
-
-
23744503085
-
Aurora kinases: shining lights on the therapeutic horizon?
-
Andrews, P.D. (2005) Aurora kinases: shining lights on the therapeutic horizon? Oncogene, 24, 5005-5015.
-
(2005)
Oncogene
, vol.24
, pp. 5005-5015
-
-
Andrews, P.D.1
-
2
-
-
0344845010
-
Mitotic mechanics: the auroras come into view
-
Andrews, P.D., Knatko, E., Moore, W.J. & Swedlow, J.R. (2003) Mitotic mechanics: the auroras come into view. Current Opinion in Cell Biology, 15, 672-683.
-
(2003)
Current Opinion in Cell Biology
, vol.15
, pp. 672-683
-
-
Andrews, P.D.1
Knatko, E.2
Moore, W.J.3
Swedlow, J.R.4
-
3
-
-
0442294189
-
Aurora B regulates MCAK at the mitotic centromere
-
Andrews, P.D., Ovechkina, Y., Morrice, N., Wagenbach, M., Duncan, K., Wordeman, L. & Swedlow, J.R. (2004) Aurora B regulates MCAK at the mitotic centromere. Developmental Cell, 6, 253-268.
-
(2004)
Developmental Cell
, vol.6
, pp. 253-268
-
-
Andrews, P.D.1
Ovechkina, Y.2
Morrice, N.3
Wagenbach, M.4
Duncan, K.5
Wordeman, L.6
Swedlow, J.R.7
-
4
-
-
1842589396
-
High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas
-
Araki, K., Nozaki, K., Ueba, T., Tatsuka, M. & Hashimoto, N. (2004) High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. Journal of Neuro-Oncology, 67, 53-64.
-
(2004)
Journal of Neuro-Oncology
, vol.67
, pp. 53-64
-
-
Araki, K.1
Nozaki, K.2
Ueba, T.3
Tatsuka, M.4
Hashimoto, N.5
-
5
-
-
34948901399
-
Aurora-A: the maker and breaker of spindle poles
-
Barr, A.R. & Gergely, F. (2007) Aurora-A: the maker and breaker of spindle poles. Journal of Cell Science, 120, 2987-2996.
-
(2007)
Journal of Cell Science
, vol.120
, pp. 2987-2996
-
-
Barr, A.R.1
Gergely, F.2
-
6
-
-
0032100685
-
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
-
Bischoff, J.R., Anderson, L., Zhu, Y., Mossie, K., Ng, L., Souza, B., Schryver, B., Flanagan, P., Clairvoyant, F., Ginther, C., Chan, C.S., Novotny, M., Slamon, D.J. & Plowman, G.D. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO Journal, 17, 3052-3065.
-
(1998)
EMBO Journal
, vol.17
, pp. 3052-3065
-
-
Bischoff, J.R.1
Anderson, L.2
Zhu, Y.3
Mossie, K.4
Ng, L.5
Souza, B.6
Schryver, B.7
Flanagan, P.8
Clairvoyant, F.9
Ginther, C.10
Chan, C.S.11
Novotny, M.12
Slamon, D.J.13
Plowman, G.D.14
-
7
-
-
33847265438
-
Aurora-A amplification associated with BRCA2 mutation in breast tumours
-
Bodvarsdottir, S.K., Hilmarsdottir, H., Birgisdottir, V., Steinarsdottir, M., Jonasson, J.G. & Eyfjord, J.E. (2007) Aurora-A amplification associated with BRCA2 mutation in breast tumours. Cancer Letters, 248, 96-102.
-
(2007)
Cancer Letters
, vol.248
, pp. 96-102
-
-
Bodvarsdottir, S.K.1
Hilmarsdottir, H.2
Birgisdottir, V.3
Steinarsdottir, M.4
Jonasson, J.G.5
Eyfjord, J.E.6
-
8
-
-
34247578600
-
Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells
-
Burkard, M.E., Randall, C.L., Larochelle, S., Zhang, C., Shokat, K.M., Fisher, R.P. & Jallepalli, P.V. (2007) Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 4383-4388.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, pp. 4383-4388
-
-
Burkard, M.E.1
Randall, C.L.2
Larochelle, S.3
Zhang, C.4
Shokat, K.M.5
Fisher, R.P.6
Jallepalli, P.V.7
-
9
-
-
66249133671
-
Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells
-
Burkard, M.E., Maciejowski, J., Rodriguez-Bravo, V., Repka, M., Lowery, D.M., Clauser, K.R., Zhang, C., Shokat, K.M., Carr, S.A., Yaffe, M.B. & Jallepalli, P.V. (2009) Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells. PLoS Biology, 7, e1000111.
-
(2009)
PLoS Biology
, vol.7
-
-
Burkard, M.E.1
Maciejowski, J.2
Rodriguez-Bravo, V.3
Repka, M.4
Lowery, D.M.5
Clauser, K.R.6
Zhang, C.7
Shokat, K.M.8
Carr, S.A.9
Yaffe, M.B.10
Jallepalli, P.V.11
-
10
-
-
28844434110
-
Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma
-
Camacho, E., Bea, S., Salaverria, I., Lopez-Guillermo, A., Puig, X., Benavente, Y., de Sanjose, S., Campo, E. & Hernandez, L. (2006) Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma. International Journal of Cancer, 118, 357-363.
-
(2006)
International Journal of Cancer
, vol.118
, pp. 357-363
-
-
Camacho, E.1
Bea, S.2
Salaverria, I.3
Lopez-Guillermo, A.4
Puig, X.5
Benavente, Y.6
de Sanjose, S.7
Campo, E.8
Hernandez, L.9
-
12
-
-
51549085203
-
Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora
-
Chan, E.H., Santamaria, A., Sillje, H.H. & Nigg, E.A. (2008) Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora. Chromosoma, 117, 457-469.
-
(2008)
Chromosoma
, vol.117
, pp. 457-469
-
-
Chan, E.H.1
Santamaria, A.2
Sillje, H.H.3
Nigg, E.A.4
-
13
-
-
0030922231
-
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
-
Chesi, M., Nardini, E., Brents, L.A., Schrock, E., Ried, T., Kuehl, W.M. & Bergsagel, P.L. (1997) Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genetics, 16, 260-264.
-
(1997)
Nature Genetics
, vol.16
, pp. 260-264
-
-
Chesi, M.1
Nardini, E.2
Brents, L.A.3
Schrock, E.4
Ried, T.5
Kuehl, W.M.6
Bergsagel, P.L.7
-
14
-
-
0035254612
-
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
-
Chesi, M., Brents, L.A., Ely, S.A., Bais, C., Robbiani, D.F., Mesri, E.A., Kuehl, W.M. & Bergsagel, P.L. (2001) Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood, 97, 729-736.
-
(2001)
Blood
, vol.97
, pp. 729-736
-
-
Chesi, M.1
Brents, L.A.2
Ely, S.A.3
Bais, C.4
Robbiani, D.F.5
Mesri, E.A.6
Kuehl, W.M.7
Bergsagel, P.L.8
-
15
-
-
38949203768
-
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition
-
Chng, W.J., Braggio, E., Mulligan, G., Bryant, B., Remstein, E., Valdez, R., Dogan, A. & Fonseca, R. (2008) The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition. Blood, 111, 1603-1609.
-
(2008)
Blood
, vol.111
, pp. 1603-1609
-
-
Chng, W.J.1
Braggio, E.2
Mulligan, G.3
Bryant, B.4
Remstein, E.5
Valdez, R.6
Dogan, A.7
Fonseca, R.8
-
16
-
-
68949138161
-
Preliminary clinical activity in a phase I trial of the BCR-ABL/IGF-1R/Aurora Kinase inhibitor XL228 in patients with Ph++ leukemias with either failure to multiple TKI therapies or with T315I mutation
-
Cortes, J., Paquette, R., Talpaz, M., Pinilla, J., Asatiani, E., Wetzler, M., Lipton, J.H., Kasap, C., Bui, L.A., Clary, D.O. & Shah, N. (2008a) Preliminary clinical activity in a phase I trial of the BCR-ABL/IGF-1R/Aurora Kinase inhibitor XL228 in patients with Ph++ leukemias with either failure to multiple TKI therapies or with T315I mutation. Blood (ASH Annual Meeting Abstracts), 112, 3232.
-
(2008)
Blood (ASH Annual Meeting Abstracts)
, vol.112
, pp. 3232
-
-
Cortes, J.1
Paquette, R.2
Talpaz, M.3
Pinilla, J.4
Asatiani, E.5
Wetzler, M.6
Lipton, J.H.7
Kasap, C.8
Bui, L.A.9
Clary, D.O.10
Shah, N.11
-
17
-
-
67349137674
-
A phase I dose escalation study of KW-2449, an oral multi-kinase inhibitor against FLT3, Abl, FGFR1 and Aurora in patients with relapsed/refractory AML, ALL and MDS or resistant/intolerant CML
-
Cortes, J., Roboz, G.J., Kantarjian, H.M., Feldman, E.J., Karp, J.E., Pratz, K.W., Rao, N.S., Akinaga, S. & Levis, M.J. (2008b) A phase I dose escalation study of KW-2449, an oral multi-kinase inhibitor against FLT3, Abl, FGFR1 and Aurora in patients with relapsed/refractory AML, ALL and MDS or resistant/intolerant CML. Blood (ASH Annual Meeting Abstracts), 112, 2967.
-
(2008)
Blood (ASH Annual Meeting Abstracts)
, vol.112
, pp. 2967
-
-
Cortes, J.1
Roboz, G.J.2
Kantarjian, H.M.3
Feldman, E.J.4
Karp, J.E.5
Pratz, K.W.6
Rao, N.S.7
Akinaga, S.8
Levis, M.J.9
-
18
-
-
77950919574
-
Danusertib hydrochloride (PHA-739358), a multi-kinase Aurora inhibitor, elicits clinical benefit in advanced chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia
-
Cortes-Franco, J., Dombret, H., Schafhausen, P., Brummendorf, T.H., Boissel, N., Latini, F., Capolongo, L., Laffranchi, B. & Comis, S. (2009) Danusertib hydrochloride (PHA-739358), a multi-kinase Aurora inhibitor, elicits clinical benefit in advanced chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia. Blood (ASH Annual Meeting Abstracts), 114, 864.
-
(2009)
Blood (ASH Annual Meeting Abstracts)
, vol.114
, pp. 864
-
-
Cortes-Franco, J.1
Dombret, H.2
Schafhausen, P.3
Brummendorf, T.H.4
Boissel, N.5
Latini, F.6
Capolongo, L.7
Laffranchi, B.8
Comis, S.9
-
19
-
-
42149088289
-
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions
-
Dar, A.A., Zaika, A., Piazuelo, M.B., Correa, P., Koyama, T., Belkhiri, A., Washington, K., Castells, A., Pera, M. & El-Rifai, W. (2008) Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer, 112, 1688-1698.
-
(2008)
Cancer
, vol.112
, pp. 1688-1698
-
-
Dar, A.A.1
Zaika, A.2
Piazuelo, M.B.3
Correa, P.4
Koyama, T.5
Belkhiri, A.6
Washington, K.7
Castells, A.8
Pera, M.9
El-Rifai, W.10
-
20
-
-
60149085428
-
The aurora kinase A regulates GSK-3beta in gastric cancer cells
-
Dar, A.A., Belkhiri, A. & El-Rifai, W. (2009) The aurora kinase A regulates GSK-3beta in gastric cancer cells. Oncogene, 28, 866-875.
-
(2009)
Oncogene
, vol.28
, pp. 866-875
-
-
Dar, A.A.1
Belkhiri, A.2
El-Rifai, W.3
-
21
-
-
0013057087
-
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
-
Ditchfield, C., Johnson, V.L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N. & Taylor, S.S. (2003) Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. Journal of Cell Biology, 161, 267-280.
-
(2003)
Journal of Cell Biology
, vol.161
, pp. 267-280
-
-
Ditchfield, C.1
Johnson, V.L.2
Tighe, A.3
Ellston, R.4
Haworth, C.5
Johnson, T.6
Mortlock, A.7
Keen, N.8
Taylor, S.S.9
-
22
-
-
71849102704
-
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia
-
Donato, N.J., Fang, D., Sun, H., Giannola, D., Peterson, L.F. & Talpaz, M. (2010) Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia. Biochemical Pharmacology, 79, 688-697.
-
(2010)
Biochemical Pharmacology
, vol.79
, pp. 688-697
-
-
Donato, N.J.1
Fang, D.2
Sun, H.3
Giannola, D.4
Peterson, L.F.5
Talpaz, M.6
-
23
-
-
3042734502
-
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition
-
Dutertre, S., Cazales, M., Quaranta, M., Froment, C., Trabut, V., Dozier, C., Mirey, G., Bouche, J.P., Theis-Febvre, N., Schmitt, E., Monsarrat, B., Prigent, C. & Ducommun, B. (2004) Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. Journal of Cell Science, 117, 2523-2531.
-
(2004)
Journal of Cell Science
, vol.117
, pp. 2523-2531
-
-
Dutertre, S.1
Cazales, M.2
Quaranta, M.3
Froment, C.4
Trabut, V.5
Dozier, C.6
Mirey, G.7
Bouche, J.P.8
Theis-Febvre, N.9
Schmitt, E.10
Monsarrat, B.11
Prigent, C.12
Ducommun, B.13
-
24
-
-
39749106551
-
Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells
-
Evans, R., Naber, C., Steffler, T., Checkland, T., Keats, J., Maxwell, C., Perry, T., Chau, H., Belch, A., Pilarski, L. & Reiman, T. (2008a) Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells. Leukaemia & Lymphoma, 49, 559-569.
-
(2008)
Leukaemia & Lymphoma
, vol.49
, pp. 559-569
-
-
Evans, R.1
Naber, C.2
Steffler, T.3
Checkland, T.4
Keats, J.5
Maxwell, C.6
Perry, T.7
Chau, H.8
Belch, A.9
Pilarski, L.10
Reiman, T.11
-
25
-
-
38349108184
-
The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma
-
Evans, R.P., Naber, C., Steffler, T., Checkland, T., Maxwell, C.A., Keats, J.J., Belch, A.R., Pilarski, L.M., Lai, R. & Reiman, T. (2008b) The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma. British Journal of Haematology, 140, 295-302.
-
(2008)
British Journal of Haematology
, vol.140
, pp. 295-302
-
-
Evans, R.P.1
Naber, C.2
Steffler, T.3
Checkland, T.4
Maxwell, C.A.5
Keats, J.J.6
Belch, A.R.7
Pilarski, L.M.8
Lai, R.9
Reiman, T.10
-
26
-
-
0037446847
-
A novel mechanism for activation of the protein kinase Aurora A
-
Eyers, P.A., Erikson, E., Chen, L.G. & Maller, J.L. (2003) A novel mechanism for activation of the protein kinase Aurora A. Current Biology, 13, 691-697.
-
(2003)
Current Biology
, vol.13
, pp. 691-697
-
-
Eyers, P.A.1
Erikson, E.2
Chen, L.G.3
Maller, J.L.4
-
27
-
-
79956052434
-
Clinical activity of a novel multiple tyrosine kinase and Aurora kinase inhibitor, ENMD-2076, against multiple myeloma: interim phase I trial results
-
Farag, S., Zhang, S., Suvannasankha, A., Liang, J., O'Bryant, R., Lisa, W., Gupta, S., Bray, M., Sidor, C.F. & Abonour, R. (2010) Clinical activity of a novel multiple tyrosine kinase and Aurora kinase inhibitor, ENMD-2076, against multiple myeloma: interim phase I trial results. Blood (ASH Annual Meeting Abstracts), 116, 1957.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
, pp. 1957
-
-
Farag, S.1
Zhang, S.2
Suvannasankha, A.3
Liang, J.4
O'Bryant, R.5
Lisa, W.6
Gupta, S.7
Bray, M.8
Sidor, C.F.9
Abonour, R.10
-
28
-
-
28844477653
-
Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation
-
Fischle, W., Tseng, B.S., Dormann, H.L., Ueberheide, B.M., Garcia, B.A., Shabanowitz, J., Hunt, D.F., Funabiki, H. & Allis, C.D. (2005) Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature, 438, 1116-1122.
-
(2005)
Nature
, vol.438
, pp. 1116-1122
-
-
Fischle, W.1
Tseng, B.S.2
Dormann, H.L.3
Ueberheide, B.M.4
Garcia, B.A.5
Shabanowitz, J.6
Hunt, D.F.7
Funabiki, H.8
Allis, C.D.9
-
29
-
-
78751492146
-
ENMD-2076 Is an orally-active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action
-
Fletcher, G.C., Brokx, R.D., Denny, T.A., Hembrough, T.A., Plum, S.M., Fogler, W.E., Sidor, C.F. & Bray, M.R. (2011) ENMD-2076 Is an orally-active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action. Molecular Cancer Therapeutics, 10, 126-137.
-
(2011)
Molecular Cancer Therapeutics
, vol.10
, pp. 126-137
-
-
Fletcher, G.C.1
Brokx, R.D.2
Denny, T.A.3
Hembrough, T.A.4
Plum, S.M.5
Fogler, W.E.6
Sidor, C.F.7
Bray, M.R.8
-
30
-
-
10744223381
-
Genetics and cytogenetics of multiple myeloma: a workshop report
-
Fonseca, R., Barlogie, B., Bataille, R., Bastard, C., Bergsagel, P.L., Chesi, M., Davies, F.E., Drach, J., Greipp, P.R., Kirsch, I.R., Kuehl, W.M., Hernandez, J.M., Minvielle, S., Pilarski, L.M., Shaughnessy, Jr, J.D., Stewart, A.K. & Avet-Loiseau, H. (2004) Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Research, 64, 1546-1558.
-
(2004)
Cancer Research
, vol.64
, pp. 1546-1558
-
-
Fonseca, R.1
Barlogie, B.2
Bataille, R.3
Bastard, C.4
Bergsagel, P.L.5
Chesi, M.6
Davies, F.E.7
Drach, J.8
Greipp, P.R.9
Kirsch, I.R.10
Kuehl, W.M.11
Hernandez, J.M.12
Minvielle, S.13
Pilarski, L.M.14
Shaughnessy Jr, J.D.15
Stewart, A.K.16
Avet-Loiseau, H.17
-
31
-
-
70249100515
-
Phase I and pharmacodynamic trial of AT9283, an Aurora kinase inhibitor, in patients with refractory leukemia
-
Foran, J.M., Ravandi, F., O'Brien, S.M., Borthakur, G., Rios, M., Boone, P., Worrell, J., Mallett, K.H., Squires, M., Fazal, L.H. & Kantarjian, H.M. (2008) Phase I and pharmacodynamic trial of AT9283, an Aurora kinase inhibitor, in patients with refractory leukemia. ASCO Meeting Abstracts, 26, 2518.
-
(2008)
ASCO Meeting Abstracts
, vol.26
, pp. 2518
-
-
Foran, J.M.1
Ravandi, F.2
O'Brien, S.M.3
Borthakur, G.4
Rios, M.5
Boone, P.6
Worrell, J.7
Mallett, K.H.8
Squires, M.9
Fazal, L.H.10
Kantarjian, H.M.11
-
32
-
-
33746905089
-
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
-
Furukawa, T., Kanai, N., Shiwaku, H.O., Soga, N., Uehara, A. & Horii, A. (2006) AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer. Oncogene, 25, 4831-4839.
-
(2006)
Oncogene
, vol.25
, pp. 4831-4839
-
-
Furukawa, T.1
Kanai, N.2
Shiwaku, H.O.3
Soga, N.4
Uehara, A.5
Horii, A.6
-
33
-
-
3342887700
-
Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle
-
Gassmann, R., Carvalho, A., Henzing, A.J., Ruchaud, S., Hudson, D.F., Honda, R., Nigg, E.A., Gerloff, D.L. & Earnshaw, W.C. (2004) Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. Journal of Cell Biology, 166, 179-191.
-
(2004)
Journal of Cell Biology
, vol.166
, pp. 179-191
-
-
Gassmann, R.1
Carvalho, A.2
Henzing, A.J.3
Ruchaud, S.4
Hudson, D.F.5
Honda, R.6
Nigg, E.A.7
Gerloff, D.L.8
Earnshaw, W.C.9
-
34
-
-
41549122837
-
Aurora kinases as anticancer drug targets
-
Gautschi, O., Heighway, J., Mack, P.C., Purnell, P.R., Lara, Jr, P.N. & Gandara, D.R. (2008) Aurora kinases as anticancer drug targets. Clinical Cancer Research, 14, 1639-1648.
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 1639-1648
-
-
Gautschi, O.1
Heighway, J.2
Mack, P.C.3
Purnell, P.R.4
Lara Jr, P.N.5
Gandara, D.R.6
-
35
-
-
0033226802
-
Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases
-
Giet, R. & Prigent, C. (1999) Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. Journal of Cell Science, 112(Pt 21), 3591-3601.
-
(1999)
Journal of Cell Science
, vol.112
, Issue.PART 21
, pp. 3591-3601
-
-
Giet, R.1
Prigent, C.2
-
36
-
-
33747877023
-
The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function
-
Gizatullin, F., Yao, Y., Kung, V., Harding, M.W., Loda, M. & Shapiro, G.I. (2006) The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Research, 66, 7668-7677.
-
(2006)
Cancer Research
, vol.66
, pp. 7668-7677
-
-
Gizatullin, F.1
Yao, Y.2
Kung, V.3
Harding, M.W.4
Loda, M.5
Shapiro, G.I.6
-
37
-
-
81155124082
-
Phase 2 study of MLN8237, an investigational Aurora A kinase (AAK) inhibitor In patients with acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS)
-
Goldberg, S.L., Fenaux, P., Craig, M.D., Gyan, E., Lister, J., Kassis, J., Pigneux, A., Schiller, G.J., Jung, J., Leonard, E.J., Fingert, H. & Westervelt, P. (2010) Phase 2 study of MLN8237, an investigational Aurora A kinase (AAK) inhibitor In patients with acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS). Blood (ASH Annual Meeting Abstracts), 116, 3273.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
, pp. 3273
-
-
Goldberg, S.L.1
Fenaux, P.2
Craig, M.D.3
Gyan, E.4
Lister, J.5
Kassis, J.6
Pigneux, A.7
Schiller, G.J.8
Jung, J.9
Leonard, E.J.10
Fingert, H.11
Westervelt, P.12
-
38
-
-
43249111278
-
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I
-
Gontarewicz, A., Balabanov, S., Keller, G., Colombo, R., Graziano, A., Pesenti, E., Benten, D., Bokemeyer, C., Fiedler, W., Moll, J. & Brummendorf, T.H. (2008) Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. Blood, 111, 4355-4364.
-
(2008)
Blood
, vol.111
, pp. 4355-4364
-
-
Gontarewicz, A.1
Balabanov, S.2
Keller, G.3
Colombo, R.4
Graziano, A.5
Pesenti, E.6
Benten, D.7
Bokemeyer, C.8
Fiedler, W.9
Moll, J.10
Brummendorf, T.H.11
-
39
-
-
77954686021
-
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
-
Gorgun, G., Calabrese, E., Hideshima, T., Ecsedy, J., Perrone, G., Mani, M., Ikeda, H., Bianchi, G., Hu, Y., Cirstea, D., Santo, L., Tai, Y.T., Nahar, S., Zheng, M., Bandi, M., Carrasco, R.D., Raje, N., Munshi, N., Richardson, P. & Anderson, K.C. (2010) A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma. Blood, 115, 5202-5213.
-
(2010)
Blood
, vol.115
, pp. 5202-5213
-
-
Gorgun, G.1
Calabrese, E.2
Hideshima, T.3
Ecsedy, J.4
Perrone, G.5
Mani, M.6
Ikeda, H.7
Bianchi, G.8
Hu, Y.9
Cirstea, D.10
Santo, L.11
Tai, Y.T.12
Nahar, S.13
Zheng, M.14
Bandi, M.15
Carrasco, R.D.16
Raje, N.17
Munshi, N.18
Richardson, P.19
Anderson, K.C.20
more..
-
40
-
-
0037386929
-
Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer
-
Gritsko, T.M., Coppola, D., Paciga, J.E., Yang, L., Sun, M., Shelley, S.A., Fiorica, J.V., Nicosia, S.V. & Cheng, J.Q. (2003) Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clinical Cancer Research, 9, 1420-1426.
-
(2003)
Clinical Cancer Research
, vol.9
, pp. 1420-1426
-
-
Gritsko, T.M.1
Coppola, D.2
Paciga, J.E.3
Yang, L.4
Sun, M.5
Shelley, S.A.6
Fiorica, J.V.7
Nicosia, S.V.8
Cheng, J.Q.9
-
41
-
-
77949693761
-
The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells
-
Grundy, M., Seedhouse, C., Shang, S., Richardson, J., Russell, N. & Pallis, M. (2010) The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells. Molecular Cancer Therapeutics, 9, 661-672.
-
(2010)
Molecular Cancer Therapeutics
, vol.9
, pp. 661-672
-
-
Grundy, M.1
Seedhouse, C.2
Shang, S.3
Richardson, J.4
Russell, N.5
Pallis, M.6
-
42
-
-
18044371706
-
Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of cytokinesis
-
Guse, A., Mishima, M. & Glotzer, M. (2005) Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of cytokinesis. Current Biology, 15, 778-786.
-
(2005)
Current Biology
, vol.15
, pp. 778-786
-
-
Guse, A.1
Mishima, M.2
Glotzer, M.3
-
43
-
-
0038015849
-
Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma
-
Hamada, M., Yakushijin, Y., Ohtsuka, M., Kakimoto, M., Yasukawa, M. & Fujita, S. (2003) Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. British Journal of Haematology, 121, 439-447.
-
(2003)
British Journal of Haematology
, vol.121
, pp. 439-447
-
-
Hamada, M.1
Yakushijin, Y.2
Ohtsuka, M.3
Kakimoto, M.4
Yasukawa, M.5
Fujita, S.6
-
44
-
-
2342639645
-
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
-
Harrington, E.A., Bebbington, D., Moore, J., Rasmussen, R.K., Ajose-Adeogun, A.O., Nakayama, T., Graham, J.A., Demur, C., Hercend, T., Diu-Hercend, A., Su, M., Golec, J.M. & Miller, K.M. (2004) VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature Medicine, 10, 262-267.
-
(2004)
Nature Medicine
, vol.10
, pp. 262-267
-
-
Harrington, E.A.1
Bebbington, D.2
Moore, J.3
Rasmussen, R.K.4
Ajose-Adeogun, A.O.5
Nakayama, T.6
Graham, J.A.7
Demur, C.8
Hercend, T.9
Diu-Hercend, A.10
Su, M.11
Golec, J.M.12
Miller, K.M.13
-
45
-
-
0034612592
-
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
-
Hart, K.C., Robertson, S.C., Kanemitsu, M.Y., Meyer, A.N., Tynan, J.A. & Donoghue, D.J. (2000) Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene, 19, 3309-3320.
-
(2000)
Oncogene
, vol.19
, pp. 3309-3320
-
-
Hart, K.C.1
Robertson, S.C.2
Kanemitsu, M.Y.3
Meyer, A.N.4
Tynan, J.A.5
Donoghue, D.J.6
-
46
-
-
0038746733
-
The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint
-
Hauf, S., Cole, R.W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van Meel, J., Rieder, C.L. & Peters, J.M. (2003) The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. Journal of Cell Biology, 161, 281-294.
-
(2003)
Journal of Cell Biology
, vol.161
, pp. 281-294
-
-
Hauf, S.1
Cole, R.W.2
LaTerra, S.3
Zimmer, C.4
Schnapp, G.5
Walter, R.6
Heckel, A.7
van Meel, J.8
Rieder, C.L.9
Peters, J.M.10
-
47
-
-
32044466838
-
Exploiting the PI3K/AKT pathway for cancer drug discovery
-
Hennessy, B.T., Smith, D.L., Ram, P.T., Lu, Y. & Mills, G.B. (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews. Drug Discovery, 4, 988-1004.
-
(2005)
Nature Reviews. Drug Discovery
, vol.4
, pp. 988-1004
-
-
Hennessy, B.T.1
Smith, D.L.2
Ram, P.T.3
Lu, Y.4
Mills, G.B.5
-
48
-
-
0141429171
-
Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells
-
Hirota, T., Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Nitta, M., Hatakeyama, K. & Saya, H. (2003) Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell, 114, 585-598.
-
(2003)
Cell
, vol.114
, pp. 585-598
-
-
Hirota, T.1
Kunitoku, N.2
Sasayama, T.3
Marumoto, T.4
Zhang, D.5
Nitta, M.6
Hatakeyama, K.7
Saya, H.8
-
49
-
-
28844475262
-
Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin
-
Hirota, T., Lipp, J.J., Toh, B.H. & Peters, J.M. (2005) Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature, 438, 1176-1180.
-
(2005)
Nature
, vol.438
, pp. 1176-1180
-
-
Hirota, T.1
Lipp, J.J.2
Toh, B.H.3
Peters, J.M.4
-
50
-
-
77956588949
-
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
-
den Hollander, J., Rimpi, S., Doherty, J.R., Rudelius, M., Buck, A., Hoellein, A., Kremer, M., Graf, N., Scheerer, M., Hall, M.A., Goga, A., von Bubnoff, N., Duyster, J., Peschel, C., Cleveland, J.L., Nilsson, J.A. & Keller, U. (2010) Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood, 116, 1498-1505.
-
(2010)
Blood
, vol.116
, pp. 1498-1505
-
-
den Hollander, J.1
Rimpi, S.2
Doherty, J.R.3
Rudelius, M.4
Buck, A.5
Hoellein, A.6
Kremer, M.7
Graf, N.8
Scheerer, M.9
Hall, M.A.10
Goga, A.11
von Bubnoff, N.12
Duyster, J.13
Peschel, C.14
Cleveland, J.L.15
Nilsson, J.A.16
Keller, U.17
-
51
-
-
0034213929
-
Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway
-
Honda, K., Mihara, H., Kato, Y., Yamaguchi, A., Tanaka, H., Yasuda, H., Furukawa, K. & Urano, T. (2000) Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway. Oncogene, 19, 2812-2819.
-
(2000)
Oncogene
, vol.19
, pp. 2812-2819
-
-
Honda, K.1
Mihara, H.2
Kato, Y.3
Yamaguchi, A.4
Tanaka, H.5
Yasuda, H.6
Furukawa, K.7
Urano, T.8
-
52
-
-
66149107431
-
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma
-
Hose, D., Reme, T., Meissner, T., Moreaux, J., Seckinger, A., Lewis, J., Benes, V., Benner, A., Hundemer, M., Hielscher, T., Shaughnessy, Jr, J.D., Barlogie, B., Neben, K., Kramer, A., Hillengass, J., Bertsch, U., Jauch, A., De Vos, J., Rossi, J.F., Mohler, T., Blake, J., Zimmermann, J., Klein, B. & Goldschmidt, H. (2009) Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma. Blood, 113, 4331-4340.
-
(2009)
Blood
, vol.113
, pp. 4331-4340
-
-
Hose, D.1
Reme, T.2
Meissner, T.3
Moreaux, J.4
Seckinger, A.5
Lewis, J.6
Benes, V.7
Benner, A.8
Hundemer, M.9
Hielscher, T.10
Shaughnessy Jr, J.D.11
Barlogie, B.12
Neben, K.13
Kramer, A.14
Hillengass, J.15
Bertsch, U.16
Jauch, A.17
De Vos, J.18
Rossi, J.F.19
Mohler, T.20
Blake, J.21
Zimmermann, J.22
Klein, B.23
Goldschmidt, H.24
more..
-
53
-
-
41949102523
-
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia
-
Huang, X.F., Luo, S.K., Xu, J., Li, J., Xu, D.R., Wang, L.H., Yan, M., Wang, X.R., Wan, X.B., Zheng, F.M., Zeng, Y.X. & Liu, Q. (2008) Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia. Blood, 111, 2854-2865.
-
(2008)
Blood
, vol.111
, pp. 2854-2865
-
-
Huang, X.F.1
Luo, S.K.2
Xu, J.3
Li, J.4
Xu, D.R.5
Wang, L.H.6
Yan, M.7
Wang, X.R.8
Wan, X.B.9
Zheng, F.M.10
Zeng, Y.X.11
Liu, Q.12
-
54
-
-
79952206794
-
Anti-tumor activity of the Aurora a inhibitor MLN8237 in diffuse large B-cell lymphoma preclinical models
-
Abstract 1592.
-
Huck, J.J., Zhang, M., Hyer, M.L. & Manfredi, M.G. (2008) Anti-tumor activity of the Aurora a inhibitor MLN8237 in diffuse large B-cell lymphoma preclinical models. Blood (ASH Annual Meeting Abstracts)., 112, Abstract 1592.
-
(2008)
Blood (ASH Annual Meeting Abstracts).
, vol.112
-
-
Huck, J.J.1
Zhang, M.2
Hyer, M.L.3
Manfredi, M.G.4
-
55
-
-
34250771649
-
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
-
Ikezoe, T., Yang, J., Nishioka, C., Tasaka, T., Taniguchi, A., Kuwayama, Y., Komatsu, N., Bandobashi, K., Togitani, K., Koeffler, H.P. & Taguchi, H. (2007) A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Molecular Cancer Therapeutics, 6, 1851-1857.
-
(2007)
Molecular Cancer Therapeutics
, vol.6
, pp. 1851-1857
-
-
Ikezoe, T.1
Yang, J.2
Nishioka, C.3
Tasaka, T.4
Taniguchi, A.5
Kuwayama, Y.6
Komatsu, N.7
Bandobashi, K.8
Togitani, K.9
Koeffler, H.P.10
Taguchi, H.11
-
56
-
-
70549111347
-
Analysis of Aurora B kinase in non-Hodgkin lymphoma
-
Ikezoe, T., Takeuchi, T., Yang, J., Adachi, Y., Nishioka, C., Furihata, M., Koeffler, H.P. & Yokoyama, A. (2009) Analysis of Aurora B kinase in non-Hodgkin lymphoma. Laboratory Investigation, 89, 1364-1373.
-
(2009)
Laboratory Investigation
, vol.89
, pp. 1364-1373
-
-
Ikezoe, T.1
Takeuchi, T.2
Yang, J.3
Adachi, Y.4
Nishioka, C.5
Furihata, M.6
Koeffler, H.P.7
Yokoyama, A.8
-
57
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal, A., Siegel, R., Xu, J. & Ward, E. (2010) Cancer statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300.
-
(2010)
CA: A Cancer Journal for Clinicians
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
58
-
-
1642361744
-
Overexpression and amplification of Aurora-A in hepatocellular carcinoma
-
Jeng, Y.M., Peng, S.Y., Lin, C.Y. & Hsu, H.C. (2004) Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clinical Cancer Research, 10, 2065-2071.
-
(2004)
Clinical Cancer Research
, vol.10
, pp. 2065-2071
-
-
Jeng, Y.M.1
Peng, S.Y.2
Lin, C.Y.3
Hsu, H.C.4
-
59
-
-
1842372689
-
Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein
-
Kanai, M., Goke, M., Tsunekawa, S. & Podolsky, D.K. (1997) Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein. Journal of Chemical Biology, 272, 6621-6628.
-
(1997)
Journal of Chemical Biology
, vol.272
, pp. 6621-6628
-
-
Kanai, M.1
Goke, M.2
Tsunekawa, S.3
Podolsky, D.K.4
-
60
-
-
81155132607
-
Phase I study to assess the safety and tolerability of AZD1152 in combination with low dose cytosine arabinoside in patients with acute myeloid leukemia (AML)
-
Kantarjian, H.M., Sekeres, M.A., Ribrag, V., Rousselot, P., Garcia-Manero, G., Jabbour, E., Owen, K., Stockman, P. & Oliver, S. (2010) Phase I study to assess the safety and tolerability of AZD1152 in combination with low dose cytosine arabinoside in patients with acute myeloid leukemia (AML). Blood (ASH Annual Meeting Abstracts), 116, 656.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
, pp. 656
-
-
Kantarjian, H.M.1
Sekeres, M.A.2
Ribrag, V.3
Rousselot, P.4
Garcia-Manero, G.5
Jabbour, E.6
Owen, K.7
Stockman, P.8
Oliver, S.9
-
61
-
-
0038341158
-
The Aurora kinases: role in cell transformation and tumorigenesis
-
Katayama, H., Brinkley, W.R. & Sen, S. (2003) The Aurora kinases: role in cell transformation and tumorigenesis. Cancer and Metastasis Reviews, 22, 451-464.
-
(2003)
Cancer and Metastasis Reviews
, vol.22
, pp. 451-464
-
-
Katayama, H.1
Brinkley, W.R.2
Sen, S.3
-
62
-
-
9144251019
-
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
-
Katayama, H., Sasai, K., Kawai, H., Yuan, Z.M., Bondaruk, J., Suzuki, F., Fujii, S., Arlinghaus, R.B., Czerniak, B.A. & Sen, S. (2004) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics, 36, 55-62.
-
(2004)
Nature Genetics
, vol.36
, pp. 55-62
-
-
Katayama, H.1
Sasai, K.2
Kawai, H.3
Yuan, Z.M.4
Bondaruk, J.5
Suzuki, F.6
Fujii, S.7
Arlinghaus, R.B.8
Czerniak, B.A.9
Sen, S.10
-
63
-
-
68549120912
-
Mitotic drivers - inhibitors of the Aurora B kinase
-
Keen, N. & Taylor, S. (2009) Mitotic drivers - inhibitors of the Aurora B kinase. Cancer and Metastasis Reviews, 28, 185-195.
-
(2009)
Cancer and Metastasis Reviews
, vol.28
, pp. 185-195
-
-
Keen, N.1
Taylor, S.2
-
64
-
-
79957528550
-
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukemia and significantly increases the efficacy of nilotinib
-
Nov 21 [Epub ahead of print].
-
Kelly, K.R., Ecsedy, J., Medina, E., Mahalingam, D., Padmanabhan, S., Nawrocki, S.T., Giles, F.J. & Carew, J.S. (2010) The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukemia and significantly increases the efficacy of nilotinib. Journal of Cellular and Molecular Medicine, Nov 21 [Epub ahead of print].
-
(2010)
Journal of Cellular and Molecular Medicine
-
-
Kelly, K.R.1
Ecsedy, J.2
Medina, E.3
Mahalingam, D.4
Padmanabhan, S.5
Nawrocki, S.T.6
Giles, F.J.7
Carew, J.S.8
-
65
-
-
16644364813
-
Overexpression and amplification of STK15 in human gliomas
-
Klein, A., Reichardt, W., Jung, V., Zang, K.D., Meese, E. & Urbschat, S. (2004) Overexpression and amplification of STK15 in human gliomas. International Journal of Oncology, 25, 1789-1794.
-
(2004)
International Journal of Oncology
, vol.25
, pp. 1789-1794
-
-
Klein, A.1
Reichardt, W.2
Jung, V.3
Zang, K.D.4
Meese, E.5
Urbschat, S.6
-
66
-
-
33744730342
-
Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP
-
Klein, U.R., Nigg, E.A. & Gruneberg, U. (2006) Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Molecular Biology of the Cell, 17, 2547-2558.
-
(2006)
Molecular Biology of the Cell
, vol.17
, pp. 2547-2558
-
-
Klein, U.R.1
Nigg, E.A.2
Gruneberg, U.3
-
67
-
-
33646024346
-
HURP is part of a Ran-dependent complex involved in spindle formation
-
Koffa, M.D., Casanova, C.M., Santarella, R., Kocher, T., Wilm, M. & Mattaj, I.W. (2006) HURP is part of a Ran-dependent complex involved in spindle formation. Current Biology, 16, 743-754.
-
(2006)
Current Biology
, vol.16
, pp. 743-754
-
-
Koffa, M.D.1
Casanova, C.M.2
Santarella, R.3
Kocher, T.4
Wilm, M.5
Mattaj, I.W.6
-
68
-
-
0035885955
-
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
-
Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnett, A.K., Goldstone, A.H. & Linch, D.C. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood, 98, 1752-1759.
-
(2001)
Blood
, vol.98
, pp. 1752-1759
-
-
Kottaridis, P.D.1
Gale, R.E.2
Frew, M.E.3
Harrison, G.4
Langabeer, S.E.5
Belton, A.A.6
Walker, H.7
Wheatley, K.8
Bowen, D.T.9
Burnett, A.K.10
Goldstone, A.H.11
Linch, D.C.12
-
69
-
-
79957913253
-
Combining histone deacetylase inhibitor vorinostat with Aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels
-
Kretzner, L., Scuto, A., Dino, P.M., Kowolik, C.M., Wu, J., Ventura, P., Jove, R., Forman, S.J., Yen, Y. & Kirschbaum, M.H. (2011) Combining histone deacetylase inhibitor vorinostat with Aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. Cancer Research, 71, 3912-3920.
-
(2011)
Cancer Research
, vol.71
, pp. 3912-3920
-
-
Kretzner, L.1
Scuto, A.2
Dino, P.M.3
Kowolik, C.M.4
Wu, J.5
Ventura, P.6
Jove, R.7
Forman, S.J.8
Yen, Y.9
Kirschbaum, M.H.10
-
70
-
-
0037135979
-
Human TPX2 is required for targeting Aurora-A kinase to the spindle
-
Kufer, T.A., Sillje, H.H., Korner, R., Gruss, O.J., Meraldi, P. & Nigg, E.A. (2002) Human TPX2 is required for targeting Aurora-A kinase to the spindle. Journal of Cell Biology, 158, 617-623.
-
(2002)
Journal of Cell Biology
, vol.158
, pp. 617-623
-
-
Kufer, T.A.1
Sillje, H.H.2
Korner, R.3
Gruss, O.J.4
Meraldi, P.5
Nigg, E.A.6
-
71
-
-
27944459623
-
Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma
-
Kurai, M., Shiozawa, T., Shih, H.C., Miyamoto, T., Feng, Y.Z., Kashima, H., Suzuki, A. & Konishi, I. (2005) Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma. Human Pathology, 36, 1281-1288.
-
(2005)
Human Pathology
, vol.36
, pp. 1281-1288
-
-
Kurai, M.1
Shiozawa, T.2
Shih, H.C.3
Miyamoto, T.4
Feng, Y.Z.5
Kashima, H.6
Suzuki, A.7
Konishi, I.8
-
72
-
-
33744720167
-
Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres
-
Lens, S.M., Rodriguez, J.A., Vader, G., Span, S.W., Giaccone, G. & Medema, R.H. (2006) Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Molecular Biology of the Cell, 17, 1897-1909.
-
(2006)
Molecular Biology of the Cell
, vol.17
, pp. 1897-1909
-
-
Lens, S.M.1
Rodriguez, J.A.2
Vader, G.3
Span, S.W.4
Giaccone, G.5
Medema, R.H.6
-
73
-
-
78649476052
-
Shared and separate functions of polo-like kinases and aurora kinases in cancer
-
Lens, S.M., Voest, E.E. & Medema, R.H. (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nature Reviews Cancer, 10, 825-841.
-
(2010)
Nature Reviews Cancer
, vol.10
, pp. 825-841
-
-
Lens, S.M.1
Voest, E.E.2
Medema, R.H.3
-
74
-
-
40349113288
-
Battling the hematological malignancies: the 200years' war
-
Lichtman, M.A. (2008) Battling the hematological malignancies: the 200years' war. Oncologist, 13, 126-138.
-
(2008)
Oncologist
, vol.13
, pp. 126-138
-
-
Lichtman, M.A.1
-
75
-
-
65349102972
-
The decision to enter mitosis: feedback and redundancy in the mitotic entry network
-
Lindqvist, A., Rodriguez-Bravo, V. & Medema, R.H. (2009) The decision to enter mitosis: feedback and redundancy in the mitotic entry network. Journal of Cell Biology, 185, 193-202.
-
(2009)
Journal of Cell Biology
, vol.185
, pp. 193-202
-
-
Lindqvist, A.1
Rodriguez-Bravo, V.2
Medema, R.H.3
-
76
-
-
0037180488
-
Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A
-
Littlepage, L.E., Wu, H., Andresson, T., Deanehan, J.K., Amundadottir, L.T. & Ruderman, J.V. (2002) Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proceedings of the National Academy of Sciences of the United States of America, 99, 15440-15445.
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, pp. 15440-15445
-
-
Littlepage, L.E.1
Wu, H.2
Andresson, T.3
Deanehan, J.K.4
Amundadottir, L.T.5
Ruderman, J.V.6
-
77
-
-
62149111407
-
Sensing chromosome bi-orientation by spatial separation of aurora B kinase from kinetochore substrates
-
Liu, D., Vader, G., Vromans, M.J., Lampson, M.A. & Lens, S.M. (2009) Sensing chromosome bi-orientation by spatial separation of aurora B kinase from kinetochore substrates. Science, 323, 1350-1353.
-
(2009)
Science
, vol.323
, pp. 1350-1353
-
-
Liu, D.1
Vader, G.2
Vromans, M.J.3
Lampson, M.A.4
Lens, S.M.5
-
78
-
-
77949405332
-
Aurora kinase inhibitors as anti-cancer therapy
-
Lok, W., Klein, R.Q. & Saif, M.W. (2010) Aurora kinase inhibitors as anti-cancer therapy. Anti-Cancer Drugs, 21, 339-350.
-
(2010)
Anti-Cancer Drugs
, vol.21
, pp. 339-350
-
-
Lok, W.1
Klein, R.Q.2
Saif, M.W.3
-
79
-
-
79952207806
-
Phase I/II study to assess the safety and efficacy of the Aurora B kinase inhibitor, AZD1152, in patients with advanced acute myeloid leukemia
-
Lowenberg, B., Rousselot, P., Martinelli, G., Goudie, A., Stockman, P. & Kantarjian, H. (2009) Phase I/II study to assess the safety and efficacy of the Aurora B kinase inhibitor, AZD1152, in patients with advanced acute myeloid leukemia. Blood (ASH Annual Meeting Abstracts), 114, 2080.
-
(2009)
Blood (ASH Annual Meeting Abstracts)
, vol.114
, pp. 2080
-
-
Lowenberg, B.1
Rousselot, P.2
Martinelli, G.3
Goudie, A.4
Stockman, P.5
Kantarjian, H.6
-
80
-
-
57649119787
-
Aurora A is essential for early embryonic development and tumor suppression
-
Lu, L., Wood, J., Minter-Dykhouse, K., Saunders, T., Yu, X. & Chen, J. (2008) Aurora A is essential for early embryonic development and tumor suppression. Journal of Chemical Biology, 283, 31785-31790.
-
(2008)
Journal of Chemical Biology
, vol.283
, pp. 31785-31790
-
-
Lu, L.1
Wood, J.2
Minter-Dykhouse, K.3
Saunders, T.4
Yu, X.5
Chen, J.6
-
81
-
-
51349144633
-
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
-
Macurek, L., Lindqvist, A., Lim, D., Lampson, M.A., Klompmaker, R., Freire, R., Clouin, C., Taylor, S.S., Yaffe, M.B. & Medema, R.H. (2008) Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature, 455, 119-123.
-
(2008)
Nature
, vol.455
, pp. 119-123
-
-
Macurek, L.1
Lindqvist, A.2
Lim, D.3
Lampson, M.A.4
Klompmaker, R.5
Freire, R.6
Clouin, C.7
Taylor, S.S.8
Yaffe, M.B.9
Medema, R.H.10
-
82
-
-
81155132604
-
AT9283, a novel pan-aurora/JAK-2 kinase inhibitor suppresses tumor growth in aggressive B-cell non-hodgkin's lymphoma
-
Abstract 3930.
-
Mahadevan, D., Liu, X., Persky, D.O., Miller, T.P., Squires, M.S. & Qi, W. (2010) AT9283, a novel pan-aurora/JAK-2 kinase inhibitor suppresses tumor growth in aggressive B-cell non-hodgkin's lymphoma. Blood (ASH Annual Meeting Abstracts), 116, Abstract 3930.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
-
-
Mahadevan, D.1
Liu, X.2
Persky, D.O.3
Miller, T.P.4
Squires, M.S.5
Qi, W.6
-
83
-
-
34247259822
-
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
-
Manfredi, M.G., Ecsedy, J.A., Meetze, K.A., Balani, S.K., Burenkova, O., Chen, W., Galvin, K.M., Hoar, K.M., Huck, J.J., LeRoy, P.J., Ray, E.T., Sells, T.B., Stringer, B., Stroud, S.G., Vos, T.J., Weatherhead, G.S., Wysong, D.R., Zhang, M., Bolen, J.B. & Claiborne, C.F. (2007) Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proceedings of the National Academy of Sciences of the United States of America, 104, 4106-4111.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, pp. 4106-4111
-
-
Manfredi, M.G.1
Ecsedy, J.A.2
Meetze, K.A.3
Balani, S.K.4
Burenkova, O.5
Chen, W.6
Galvin, K.M.7
Hoar, K.M.8
Huck, J.J.9
LeRoy, P.J.10
Ray, E.T.11
Sells, T.B.12
Stringer, B.13
Stroud, S.G.14
Vos, T.J.15
Weatherhead, G.S.16
Wysong, D.R.17
Zhang, M.18
Bolen, J.B.19
Claiborne, C.F.20
more..
-
84
-
-
77952703733
-
Initial testing of the aurora kinase A inhibitor MLN8237 by the pediatric preclinical testing program (PPTP)
-
Maris, J.M., Morton, C.L., Gorlick, R., Kolb, E.A., Lock, R., Carol, H., Keir, S.T., Reynolds, C.P., Kang, M.H., Wu, J., Smith, M.A. & Houghton, P.J. (2010) Initial testing of the aurora kinase A inhibitor MLN8237 by the pediatric preclinical testing program (PPTP). Pediatric Blood & Cancer, 55, 26-34.
-
(2010)
Pediatric Blood & Cancer
, vol.55
, pp. 26-34
-
-
Maris, J.M.1
Morton, C.L.2
Gorlick, R.3
Kolb, E.A.4
Lock, R.5
Carol, H.6
Keir, S.T.7
Reynolds, C.P.8
Kang, M.H.9
Wu, J.10
Smith, M.A.11
Houghton, P.J.12
-
85
-
-
71449112904
-
Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen
-
McLaughlin, J., Markovtsov, V., Li, H., Wong, S., Gelman, M., Zhu, Y., Franci, C., Lang, D.W., Pali, E., Lasaga, J., Low, C., Zhao, F., Chang, B., Gururaja, T.L., Xu, W., Baluom, M., Sweeny, D., Carroll, D., Sran, A., Thota, S., Parmer, M., Romane, A., Clemens, G., Grossbard, E., Qu, K., Jenkins, Y., Kinoshita, T., Taylor, V., Holland, S.J., Argade, A., Singh, R., Pine, P., Payan, D.G. & Hitoshi, Y. (2010) Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen. Journal of Cancer Research and Clinical Oncology, 136, 99-113.
-
(2010)
Journal of Cancer Research and Clinical Oncology
, vol.136
, pp. 99-113
-
-
McLaughlin, J.1
Markovtsov, V.2
Li, H.3
Wong, S.4
Gelman, M.5
Zhu, Y.6
Franci, C.7
Lang, D.W.8
Pali, E.9
Lasaga, J.10
Low, C.11
Zhao, F.12
Chang, B.13
Gururaja, T.L.14
Xu, W.15
Baluom, M.16
Sweeny, D.17
Carroll, D.18
Sran, A.19
Thota, S.20
Parmer, M.21
Romane, A.22
Clemens, G.23
Grossbard, E.24
Qu, K.25
Jenkins, Y.26
Kinoshita, T.27
Taylor, V.28
Holland, S.J.29
Argade, A.30
Singh, R.31
Pine, P.32
Payan, D.G.33
Hitoshi, Y.34
more..
-
86
-
-
0035342595
-
Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers
-
Miyoshi, Y., Iwao, K., Egawa, C. & Noguchi, S. (2001) Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. International Journal of Cancer, 92, 370-373.
-
(2001)
International Journal of Cancer
, vol.92
, pp. 370-373
-
-
Miyoshi, Y.1
Iwao, K.2
Egawa, C.3
Noguchi, S.4
-
87
-
-
33846809037
-
DNA methylation promotes Aurora-B-driven phosphorylation of histone H3 in chromosomal subdomains
-
Monier, K., Mouradian, S. & Sullivan, K.F. (2007) DNA methylation promotes Aurora-B-driven phosphorylation of histone H3 in chromosomal subdomains. Journal of Cell Science, 120, 101-114.
-
(2007)
Journal of Cell Science
, vol.120
, pp. 101-114
-
-
Monier, K.1
Mouradian, S.2
Sullivan, K.F.3
-
88
-
-
77950949478
-
Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias
-
Moore, A.S., Blagg, J., Linardopoulos, S. & Pearson, A.D. (2010) Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias. Leukemia, 24, 671-678.
-
(2010)
Leukemia
, vol.24
, pp. 671-678
-
-
Moore, A.S.1
Blagg, J.2
Linardopoulos, S.3
Pearson, A.D.4
-
89
-
-
34548138922
-
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
-
Moreau, P., Attal, M., Garban, F., Hulin, C., Facon, T., Marit, G., Michallet, M., Doyen, C., Leyvraz, S., Mohty, M., Wetterwald, M., Mathiot, C., Caillot, D., Berthou, C., Benboubker, L., Garderet, L., Chaleteix, C., Traulle, C., Fuzibet, J.G., Jaubert, J., Lamy, T., Casassus, P., Dib, M., Kolb, B., Dorvaux, V., Grosbois, B., Yakoub-Agha, I., Harousseau, J.L. & Avet-Loiseau, H. (2007) Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials. Leukemia, 21, 2020-2024.
-
(2007)
Leukemia
, vol.21
, pp. 2020-2024
-
-
Moreau, P.1
Attal, M.2
Garban, F.3
Hulin, C.4
Facon, T.5
Marit, G.6
Michallet, M.7
Doyen, C.8
Leyvraz, S.9
Mohty, M.10
Wetterwald, M.11
Mathiot, C.12
Caillot, D.13
Berthou, C.14
Benboubker, L.15
Garderet, L.16
Chaleteix, C.17
Traulle, C.18
Fuzibet, J.G.19
Jaubert, J.20
Lamy, T.21
Casassus, P.22
Dib, M.23
Kolb, B.24
Dorvaux, V.25
Grosbois, B.26
Yakoub-Agha, I.27
Harousseau, J.L.28
Avet-Loiseau, H.29
more..
-
90
-
-
79953690474
-
Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas
-
Mori, N., Ishikawa, C., Senba, M., Kimura, M. & Okano, Y. (2011) Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas. Biochemical Pharmacology, 81, 1106-1115.
-
(2011)
Biochemical Pharmacology
, vol.81
, pp. 1106-1115
-
-
Mori, N.1
Ishikawa, C.2
Senba, M.3
Kimura, M.4
Okano, Y.5
-
91
-
-
40649089661
-
Aurora kinases as targets for cancer therapy
-
Mountzios, G., Terpos, E. & Dimopoulos, M.A. (2008) Aurora kinases as targets for cancer therapy. Cancer Treatment Reviews, 34, 175-182.
-
(2008)
Cancer Treatment Reviews
, vol.34
, pp. 175-182
-
-
Mountzios, G.1
Terpos, E.2
Dimopoulos, M.A.3
-
92
-
-
0037018843
-
The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis
-
Murata-Hori, M. & Wang, Y.L. (2002) The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis. Current Biology, 12, 894-899.
-
(2002)
Current Biology
, vol.12
, pp. 894-899
-
-
Murata-Hori, M.1
Wang, Y.L.2
-
93
-
-
77950920037
-
The Aurora kinase inhibitor MLN8237 has potent anticancer activity in CML and Ph+ ALL models and significantly increases the efficacy of nilotinib
-
Abstract 3198.
-
Nawrocki, S.T., Medina, E., Smith, S., Swords, R., Kelly, K., Padmanabhan, S., Ecsedy, J., Giles, F.J. & Carew, J. (2008) The Aurora kinase inhibitor MLN8237 has potent anticancer activity in CML and Ph+ ALL models and significantly increases the efficacy of nilotinib. Blood (ASH Annual Meeting Abstracts), 112, Abstract 3198.
-
(2008)
Blood (ASH Annual Meeting Abstracts)
, vol.112
-
-
Nawrocki, S.T.1
Medina, E.2
Smith, S.3
Swords, R.4
Kelly, K.5
Padmanabhan, S.6
Ecsedy, J.7
Giles, F.J.8
Carew, J.9
-
94
-
-
70449387257
-
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465
-
Negri, J.M., McMillin, D.W., Delmore, J., Mitsiades, N., Hayden, P., Klippel, S., Hideshima, T., Chauhan, D., Munshi, N.C., Buser, C.A., Pollard, J., Richardson, P.G., Anderson, K.C. & Mitsiades, C.S. (2009) In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465. British Journal of Haematology, 147, 672-676.
-
(2009)
British Journal of Haematology
, vol.147
, pp. 672-676
-
-
Negri, J.M.1
McMillin, D.W.2
Delmore, J.3
Mitsiades, N.4
Hayden, P.5
Klippel, S.6
Hideshima, T.7
Chauhan, D.8
Munshi, N.C.9
Buser, C.A.10
Pollard, J.11
Richardson, P.G.12
Anderson, K.C.13
Mitsiades, C.S.14
-
95
-
-
34548253898
-
High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers
-
Nishida, N., Nagasaka, T., Kashiwagi, K., Boland, C.R. & Goel, A. (2007) High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers. Cancer Biology & Therapy, 6, 525-533.
-
(2007)
Cancer Biology & Therapy
, vol.6
, pp. 525-533
-
-
Nishida, N.1
Nagasaka, T.2
Kashiwagi, K.3
Boland, C.R.4
Goel, A.5
-
96
-
-
1642323740
-
Protein kinase inhibitors: insights into drug design from structure
-
Noble, M.E., Endicott, J.A. & Johnson, L.N. (2004) Protein kinase inhibitors: insights into drug design from structure. Science, 303, 1800-1805.
-
(2004)
Science
, vol.303
, pp. 1800-1805
-
-
Noble, M.E.1
Endicott, J.A.2
Johnson, L.N.3
-
97
-
-
0033472710
-
Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation
-
Otsuki, T., Yamada, O., Yata, K., Sakaguchi, H., Kurebayashi, J., Nakazawa, N., Taniwaki, M., Yawata, Y. & Ueki, A. (1999) Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation. International Journal of Oncology, 15, 1205-1212.
-
(1999)
International Journal of Oncology
, vol.15
, pp. 1205-1212
-
-
Otsuki, T.1
Yamada, O.2
Yata, K.3
Sakaguchi, H.4
Kurebayashi, J.5
Nakazawa, N.6
Taniwaki, M.7
Yawata, Y.8
Ueki, A.9
-
98
-
-
79251534367
-
p53: the attractive tumor suppressor in the cancer research field
-
Ozaki, T. & Nakagawara, A. (2011) p53: the attractive tumor suppressor in the cancer research field. Journal of Biomedicine and Biotechnology, 2011, 603925.
-
(2011)
Journal of Biomedicine and Biotechnology
, vol.2011
, pp. 603925
-
-
Ozaki, T.1
Nakagawara, A.2
-
99
-
-
81155151133
-
Phase I study of an investigational Aurora A kinase inhibitor MLN8237 In patients with advanced hematologic malignancies
-
Padmanabhan, S., Shea, T.C., Vose, J.M., Reeder, C.B., Berdeja, J.G., McDonagh, K.T., Goy, A., Kelly, K.R., Zhou, X., Liu, H., Fingert, H. & Fowler, N. (2010) Phase I study of an investigational Aurora A kinase inhibitor MLN8237 In patients with advanced hematologic malignancies. Blood (ASH Annual Meeting Abstracts), 116, 2799.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
, pp. 2799
-
-
Padmanabhan, S.1
Shea, T.C.2
Vose, J.M.3
Reeder, C.B.4
Berdeja, J.G.5
McDonagh, K.T.6
Goy, A.7
Kelly, K.R.8
Zhou, X.9
Liu, H.10
Fingert, H.11
Fowler, N.12
-
100
-
-
1542329588
-
Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma
-
Paterson, J.L., Li, Z., Wen, X.Y., Masih-Khan, E., Chang, H., Pollett, J.B., Trudel, S. & Stewart, A.K. (2004) Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma. British Journal of Haematology, 124, 595-603.
-
(2004)
British Journal of Haematology
, vol.124
, pp. 595-603
-
-
Paterson, J.L.1
Li, Z.2
Wen, X.Y.3
Masih-Khan, E.4
Chang, H.5
Pollett, J.B.6
Trudel, S.7
Stewart, A.K.8
-
102
-
-
34247611900
-
Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle
-
Petronczki, M., Glotzer, M., Kraut, N. & Peters, J.M. (2007) Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. Developmental Cell, 12, 713-725.
-
(2007)
Developmental Cell
, vol.12
, pp. 713-725
-
-
Petronczki, M.1
Glotzer, M.2
Kraut, N.3
Peters, J.M.4
-
103
-
-
0034142212
-
Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis
-
Plowright, E.E., Li, Z., Bergsagel, P.L., Chesi, M., Barber, D.L., Branch, D.R., Hawley, R.G. & Stewart, A.K. (2000) Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis. Blood, 95, 992-998.
-
(2000)
Blood
, vol.95
, pp. 992-998
-
-
Plowright, E.E.1
Li, Z.2
Bergsagel, P.L.3
Chesi, M.4
Barber, D.L.5
Branch, D.R.6
Hawley, R.G.7
Stewart, A.K.8
-
104
-
-
65649152925
-
Discovery and development of aurora kinase inhibitors as anticancer agents
-
Pollard, D. & Mortimore, M. (2009) Discovery and development of aurora kinase inhibitors as anticancer agents. Journal of Medicinal Chemistry, 52, 2629-2651.
-
(2009)
Journal of Medicinal Chemistry
, vol.52
, pp. 2629-2651
-
-
Pollard, D.1
Mortimore, M.2
-
105
-
-
62949087552
-
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
-
Pratz, K.W., Cortes, J., Roboz, G.J., Rao, N., Arowojolu, O., Stine, A., Shiotsu, Y., Shudo, A., Akinaga, S., Small, D., Karp, J.E. & Levis, M. (2009) A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response. Blood, 113, 3938-3946.
-
(2009)
Blood
, vol.113
, pp. 3938-3946
-
-
Pratz, K.W.1
Cortes, J.2
Roboz, G.J.3
Rao, N.4
Arowojolu, O.5
Stine, A.6
Shiotsu, Y.7
Shudo, A.8
Akinaga, S.9
Small, D.10
Karp, J.E.11
Levis, M.12
-
106
-
-
79952565110
-
Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
-
Qi, W., Cooke, L.S., Liu, X., Rimsza, L., Roe, D.J., Manziolli, A., Persky, D.O., Miller, T.P. & Mahadevan, D. (2011) Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma. Biochemical Pharmacology, 81, 881-890.
-
(2011)
Biochemical Pharmacology
, vol.81
, pp. 881-890
-
-
Qi, W.1
Cooke, L.S.2
Liu, X.3
Rimsza, L.4
Roe, D.J.5
Manziolli, A.6
Persky, D.O.7
Miller, T.P.8
Mahadevan, D.9
-
107
-
-
34848929062
-
Flying under the radar: the new wave of BCR-ABL inhibitors
-
Quintas-Cardama, A., Kantarjian, H. & Cortes, J. (2007) Flying under the radar: the new wave of BCR-ABL inhibitors. Nature Reviews. Drug Discovery, 6, 834-848.
-
(2007)
Nature Reviews. Drug Discovery
, vol.6
, pp. 834-848
-
-
Quintas-Cardama, A.1
Kantarjian, H.2
Cortes, J.3
-
108
-
-
2142746397
-
The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas
-
Reichardt, W., Jung, V., Brunner, C., Klein, A., Wemmert, S., Romeike, B.F., Zang, K.D. & Urbschat, S. (2003) The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncology Reports, 10, 1275-1279.
-
(2003)
Oncology Reports
, vol.10
, pp. 1275-1279
-
-
Reichardt, W.1
Jung, V.2
Brunner, C.3
Klein, A.4
Wemmert, S.5
Romeike, B.F.6
Zang, K.D.7
Urbschat, S.8
-
109
-
-
34648825331
-
Chromosomal passengers: conducting cell division
-
Ruchaud, S., Carmena, M. & Earnshaw, W.C. (2007) Chromosomal passengers: conducting cell division. Nature Reviews. Molecular Cell Biology, 8, 798-812.
-
(2007)
Nature Reviews. Molecular Cell Biology
, vol.8
, pp. 798-812
-
-
Ruchaud, S.1
Carmena, M.2
Earnshaw, W.C.3
-
110
-
-
81155151135
-
AT9283, a small molecule multi-targeted kinase inhibitor with potent activity against Aurora kinase and STAT3 In combination with lenalidomide results in synergistic anti-myeloma activity
-
Santo, L., Hideshima, T., Cirstea, D., Bandi, M.L., Nelson, E.A., Ikeda, H., Vallet, S., Pozzi, S., Patel, K., Gorgun, G., Mimura, N., Fabre, C., Hu, Y., Chauhan, D., Squires, M.S., Munshi, N.C., Anderson, K.C. & Raje, N. (2010) AT9283, a small molecule multi-targeted kinase inhibitor with potent activity against Aurora kinase and STAT3 In combination with lenalidomide results in synergistic anti-myeloma activity. Blood (ASH Annual Meeting Abstracts), 116, 2994.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
, pp. 2994
-
-
Santo, L.1
Hideshima, T.2
Cirstea, D.3
Bandi, M.L.4
Nelson, E.A.5
Ikeda, H.6
Vallet, S.7
Pozzi, S.8
Patel, K.9
Gorgun, G.10
Mimura, N.11
Fabre, C.12
Hu, Y.13
Chauhan, D.14
Squires, M.S.15
Munshi, N.C.16
Anderson, K.C.17
Raje, N.18
-
111
-
-
79956014006
-
Anti-myeloma activity of a multi targeted kinase inhibitor, AT9283, via potent Aurora Kinase and STAT3 inhibition either alone or in combination with lenalidomide
-
Santo, L., Hideshima, T., Cirstea, D., Bandi, M., Nelson, E.A., Gorgun, G., Rodig, S.J., Vallet, S., Pozzi, S., Patel, K., Unitt, C.L., Squires, M.S., Hu, Y., Chauhan, D., Mahindra, A., Munshi, N.C., Anderson, K.C. & Raje, N.S. (2011) Anti-myeloma activity of a multi targeted kinase inhibitor, AT9283, via potent Aurora Kinase and STAT3 inhibition either alone or in combination with lenalidomide. Clinical Cancer Research, 17, 3259-3271.
-
(2011)
Clinical Cancer Research
, vol.17
, pp. 3259-3271
-
-
Santo, L.1
Hideshima, T.2
Cirstea, D.3
Bandi, M.4
Nelson, E.A.5
Gorgun, G.6
Rodig, S.J.7
Vallet, S.8
Pozzi, S.9
Patel, K.10
Unitt, C.L.11
Squires, M.S.12
Hu, Y.13
Chauhan, D.14
Mahindra, A.15
Munshi, N.C.16
Anderson, K.C.17
Raje, N.S.18
-
112
-
-
19944394833
-
Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells
-
Sasai, K., Katayama, H., Stenoien, D.L., Fujii, S., Honda, R., Kimura, M., Okano, Y., Tatsuka, M., Suzuki, F., Nigg, E.A., Earnshaw, W.C., Brinkley, W.R. & Sen, S. (2004) Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motility and the Cytoskeleton, 59, 249-263.
-
(2004)
Cell Motility and the Cytoskeleton
, vol.59
, pp. 249-263
-
-
Sasai, K.1
Katayama, H.2
Stenoien, D.L.3
Fujii, S.4
Honda, R.5
Kimura, M.6
Okano, Y.7
Tatsuka, M.8
Suzuki, F.9
Nigg, E.A.10
Earnshaw, W.C.11
Brinkley, W.R.12
Sen, S.13
-
113
-
-
2942590333
-
Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein
-
Satinover, D.L., Leach, C.A., Stukenberg, P.T. & Brautigan, D.L. (2004) Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein. Proceedings of the National Academy of Sciences of the United States of America, 101, 8625-8630.
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, pp. 8625-8630
-
-
Satinover, D.L.1
Leach, C.A.2
Stukenberg, P.T.3
Brautigan, D.L.4
-
114
-
-
33646701199
-
The crystal structure of the small GTPase Rab11b reveals critical differences relative to the Rab11a isoform
-
Scapin, S., Carneiro, F., Alves, A., Medrano, F., Guimaraes, B. & Zanchin, N. (2006) The crystal structure of the small GTPase Rab11b reveals critical differences relative to the Rab11a isoform. Journal of Structural Biology, 154, 260-268.
-
(2006)
Journal of Structural Biology
, vol.154
, pp. 260-268
-
-
Scapin, S.1
Carneiro, F.2
Alves, A.3
Medrano, F.4
Guimaraes, B.5
Zanchin, N.6
-
115
-
-
79952164706
-
Activity of Serono-AS703569, a dual inhibitor of Bcr-Abl and Aurora kinases in Bcr-Abl transformed cells, is dependent on Aurora B inhibition, and is not affected by the presence of the highly imatinib resistant Bcr-Abl mutation T315I
-
Seitz, A.K., von Bubnoff, N., Sarno, S.M., Peschel, C. & Duyster, J. (2009) Activity of Serono-AS703569, a dual inhibitor of Bcr-Abl and Aurora kinases in Bcr-Abl transformed cells, is dependent on Aurora B inhibition, and is not affected by the presence of the highly imatinib resistant Bcr-Abl mutation T315I. Blood (ASH Annual Meeting Abstracts), 114, 3247.
-
(2009)
Blood (ASH Annual Meeting Abstracts)
, vol.114
, pp. 3247
-
-
Seitz, A.K.1
von Bubnoff, N.2
Sarno, S.M.3
Peschel, C.4
Duyster, J.5
-
116
-
-
0030962953
-
A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines
-
Sen, S., Zhou, H. & White, R.A. (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene, 14, 2195-2200.
-
(1997)
Oncogene
, vol.14
, pp. 2195-2200
-
-
Sen, S.1
Zhou, H.2
White, R.A.3
-
117
-
-
0037019736
-
Amplification/overexpression of a mitotic kinase gene in human bladder cancer
-
Sen, S., Zhou, H., Zhang, R.D., Yoon, D.S., Vakar-Lopez, F., Ito, S., Jiang, F., Johnston, D., Grossman, H.B., Ruifrok, A.C., Katz, R.L., Brinkley, W. & Czerniak, B. (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. Journal of the National Cancer Institute, 94, 1320-1329.
-
(2002)
Journal of the National Cancer Institute
, vol.94
, pp. 1320-1329
-
-
Sen, S.1
Zhou, H.2
Zhang, R.D.3
Yoon, D.S.4
Vakar-Lopez, F.5
Ito, S.6
Jiang, F.7
Johnston, D.8
Grossman, H.B.9
Ruifrok, A.C.10
Katz, R.L.11
Brinkley, W.12
Czerniak, B.13
-
118
-
-
20844436307
-
Mechanism of Aurora B activation by INCENP and inhibition by hesperadin
-
Sessa, F., Mapelli, M., Ciferri, C., Tarricone, C., Areces, L.B., Schneider, T.R., Stukenberg, P.T. & Musacchio, A. (2005) Mechanism of Aurora B activation by INCENP and inhibition by hesperadin. Molecular Cell, 18, 379-391.
-
(2005)
Molecular Cell
, vol.18
, pp. 379-391
-
-
Sessa, F.1
Mapelli, M.2
Ciferri, C.3
Tarricone, C.4
Areces, L.B.5
Schneider, T.R.6
Stukenberg, P.T.7
Musacchio, A.8
-
119
-
-
70349566478
-
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation
-
Shiotsu, Y., Kiyoi, H., Ishikawa, Y., Tanizaki, R., Shimizu, M., Umehara, H., Ishii, K., Mori, Y., Ozeki, K., Minami, Y., Abe, A., Maeda, H., Akiyama, T., Kanda, Y., Sato, Y., Akinaga, S. & Naoe, T. (2009) KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation. Blood, 114, 1607-1617.
-
(2009)
Blood
, vol.114
, pp. 1607-1617
-
-
Shiotsu, Y.1
Kiyoi, H.2
Ishikawa, Y.3
Tanizaki, R.4
Shimizu, M.5
Umehara, H.6
Ishii, K.7
Mori, Y.8
Ozeki, K.9
Minami, Y.10
Abe, A.11
Maeda, H.12
Akiyama, T.13
Kanda, Y.14
Sato, Y.15
Akinaga, S.16
Naoe, T.17
-
120
-
-
27144532389
-
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
-
Smith, S.L., Bowers, N.L., Betticher, D.C., Gautschi, O., Ratschiller, D., Hoban, P.R., Booton, R., Santibanez-Koref, M.F. & Heighway, J. (2005) Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. British Journal of Cancer, 93, 719-729.
-
(2005)
British Journal of Cancer
, vol.93
, pp. 719-729
-
-
Smith, S.L.1
Bowers, N.L.2
Betticher, D.C.3
Gautschi, O.4
Ratschiller, D.5
Hoban, P.R.6
Booton, R.7
Santibanez-Koref, M.F.8
Heighway, J.9
-
121
-
-
67649905530
-
Phase I, dose-escalation study of 2 dosing regimens of AS703569, an inhibitor of aurora and other kinases, administered orally in patients with advanced hematological malignancies
-
Sonet, A., Graux, C., Maertens, J., Hartog, C.-M., Duyster, J., Gotze, K., Greiner, J., Hutter, M.-L., Gratwohl, A., Heim, D., Hess, D., Chalandon, Y., Gianella-Borradori, A., Rejeb, N. & Ottmann, O. (2008) Phase I, dose-escalation study of 2 dosing regimens of AS703569, an inhibitor of aurora and other kinases, administered orally in patients with advanced hematological malignancies. Blood (ASH Annual Meeting Abstracts), 112, 2963.
-
(2008)
Blood (ASH Annual Meeting Abstracts)
, vol.112
, pp. 2963
-
-
Sonet, A.1
Graux, C.2
Maertens, J.3
Hartog, C.-M.4
Duyster, J.5
Gotze, K.6
Greiner, J.7
Hutter, M.-L.8
Gratwohl, A.9
Heim, D.10
Hess, D.11
Chalandon, Y.12
Gianella-Borradori, A.13
Rejeb, N.14
Ottmann, O.15
-
122
-
-
33846228789
-
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia
-
GIMEMA Working Party on Chronic Myeloid Leukemia () .
-
Soverini, S., Colarossi, S., Gnani, A., Rosti, G., Castagnetti, F., Poerio, A., Iacobucci, I., Amabile, M., Abruzzese, E., Orlandi, E., Radaelli, F., Ciccone, F., Tiribelli, M., di Lorenzo, R., Caracciolo, C., Izzo, B., Pane, F., Saglio, G., Baccarani, M., Martinelli, G., GIMEMA Working Party on Chronic Myeloid Leukemia (2006) Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia. Clinical Cancer Research, 12, 7374-7379.
-
(2006)
Clinical Cancer Research
, vol.12
, pp. 7374-7379
-
-
Soverini, S.1
Colarossi, S.2
Gnani, A.3
Rosti, G.4
Castagnetti, F.5
Poerio, A.6
Iacobucci, I.7
Amabile, M.8
Abruzzese, E.9
Orlandi, E.10
Radaelli, F.11
Ciccone, F.12
Tiribelli, M.13
di Lorenzo, R.14
Caracciolo, C.15
Izzo, B.16
Pane, F.17
Saglio, G.18
Baccarani, M.19
Martinelli, G.20
more..
-
123
-
-
84856072919
-
Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
-
Steeghs, N., Mathijssen, R.H., Wessels, J.A., de Graan, A.J., van der Straaten, T., Mariani, M., Laffranchi, B., Comis, S., de Jonge, M.J., Gelderblom, H. & Guchelaar, H.J. (2010) Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib. Investigational New Drugs, 29, 953-962.
-
(2010)
Investigational New Drugs
, vol.29
, pp. 953-962
-
-
Steeghs, N.1
Mathijssen, R.H.2
Wessels, J.A.3
de Graan, A.J.4
van der Straaten, T.5
Mariani, M.6
Laffranchi, B.7
Comis, S.8
de Jonge, M.J.9
Gelderblom, H.10
Guchelaar, H.J.11
-
124
-
-
33751426181
-
Aurora kinase inhibition downregulates NF-kappaB and sensitises tumour cells to chemotherapeutic agents
-
Sun, C., Chan, F., Briassouli, P. & Linardopoulos, S. (2007) Aurora kinase inhibition downregulates NF-kappaB and sensitises tumour cells to chemotherapeutic agents. Biochemical and Biophysical Research Communications, 352, 220-225.
-
(2007)
Biochemical and Biophysical Research Communications
, vol.352
, pp. 220-225
-
-
Sun, C.1
Chan, F.2
Briassouli, P.3
Linardopoulos, S.4
-
125
-
-
67649936622
-
Activity of the multi-targeted kinase inhibitor, AT9283 on imatinib-resistant CML models
-
Tanaka, R., Squires, M.S., Kimura, S., Yokota, A., Mallett, K., Smyth, T., Thompson, N.T., Nagao, R., Yamauchi, T., Ushiki, T., Lyons, J.F. & Maekawa, T. (2008) Activity of the multi-targeted kinase inhibitor, AT9283 on imatinib-resistant CML models. Blood (ASH Annual Meeting Abstracts), 112, 1104.
-
(2008)
Blood (ASH Annual Meeting Abstracts)
, vol.112
, pp. 1104
-
-
Tanaka, R.1
Squires, M.S.2
Kimura, S.3
Yokota, A.4
Mallett, K.5
Smyth, T.6
Thompson, N.T.7
Nagao, R.8
Yamauchi, T.9
Ushiki, T.10
Lyons, J.F.11
Maekawa, T.12
-
126
-
-
13944254035
-
Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis
-
Tatsuka, M., Sato, S., Kitajima, S., Suto, S., Kawai, H., Miyauchi, M., Ogawa, I., Maeda, M., Ota, T. & Takata, T. (2005) Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene, 24, 1122-1127.
-
(2005)
Oncogene
, vol.24
, pp. 1122-1127
-
-
Tatsuka, M.1
Sato, S.2
Kitajima, S.3
Suto, S.4
Kawai, H.5
Miyauchi, M.6
Ogawa, I.7
Maeda, M.8
Ota, T.9
Takata, T.10
-
127
-
-
0032472915
-
AIM-1: a mammalian midbody-associated protein required for cytokinesis
-
Terada, Y., Tatsuka, M., Suzuki, F., Yasuda, Y., Fujita, S. & Otsu, M. (1998) AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO Journal, 17, 667-676.
-
(1998)
EMBO Journal
, vol.17
, pp. 667-676
-
-
Terada, Y.1
Tatsuka, M.2
Suzuki, F.3
Yasuda, Y.4
Fujita, S.5
Otsu, M.6
-
128
-
-
77956601131
-
Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro
-
Tomita, M., Tanaka, Y. & Mori, N. (2010) Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro. International Journal of Cancer, 127, 1584-1594.
-
(2010)
International Journal of Cancer
, vol.127
, pp. 1584-1594
-
-
Tomita, M.1
Tanaka, Y.2
Mori, N.3
-
129
-
-
33745275629
-
The chromosomal passenger complex: guiding Aurora-B through mitosis
-
Vader, G., Medema, R.H. & Lens, S.M. (2006) The chromosomal passenger complex: guiding Aurora-B through mitosis. Journal of Cell Biology, 173, 833-837.
-
(2006)
Journal of Cell Biology
, vol.173
, pp. 833-837
-
-
Vader, G.1
Medema, R.H.2
Lens, S.M.3
-
130
-
-
45849128289
-
The chromosomal passenger complex and the spindle assembly checkpoint: kinetochore-microtubule error correction and beyond
-
Vader, G., Maia, A.F. & Lens, S.M. (2008) The chromosomal passenger complex and the spindle assembly checkpoint: kinetochore-microtubule error correction and beyond. Cell Division, 3, 10.
-
(2008)
Cell Division
, vol.3
, pp. 10
-
-
Vader, G.1
Maia, A.F.2
Lens, S.M.3
-
131
-
-
4444321565
-
Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells
-
van Vugt, M.A., Bras, A. & Medema, R.H. (2004) Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Molecular Cell, 15, 799-811.
-
(2004)
Molecular Cell
, vol.15
, pp. 799-811
-
-
van Vugt, M.A.1
Bras, A.2
Medema, R.H.3
-
132
-
-
77954599491
-
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma
-
Wang, X., Sinn, A.L., Pollok, K., Sandusky, G., Zhang, S., Chen, L., Liang, J., Crean, C.D., Suvannasankha, A., Abonour, R., Sidor, C., Bray, M.R. & Farag, S.S. (2010) Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma. British Journal of Haematology, 150, 313-325.
-
(2010)
British Journal of Haematology
, vol.150
, pp. 313-325
-
-
Wang, X.1
Sinn, A.L.2
Pollok, K.3
Sandusky, G.4
Zhang, S.5
Chen, L.6
Liang, J.7
Crean, C.D.8
Suvannasankha, A.9
Abonour, R.10
Sidor, C.11
Bray, M.R.12
Farag, S.S.13
-
133
-
-
1842428734
-
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP
-
Watanabe, N., Arai, H., Nishihara, Y., Taniguchi, M., Watanabe, N., Hunter, T. & Osada, H. (2004) M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proceedings of the National Academy of Sciences of the United States of America, 101, 4419-4424.
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, pp. 4419-4424
-
-
Watanabe, N.1
Arai, H.2
Nishihara, Y.3
Taniguchi, M.4
Watanabe, N.5
Hunter, T.6
Osada, H.7
-
135
-
-
77951952612
-
Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface
-
Welburn, J.P., Vleugel, M., Liu, D., Yates, III, J.R., Lampson, M.A., Fukagawa, T. & Cheeseman, I.M. (2010) Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface. Molecular Cell, 38, 383-392.
-
(2010)
Molecular Cell
, vol.38
, pp. 383-392
-
-
Welburn, J.P.1
Vleugel, M.2
Liu, D.3
Yates III, J.R.4
Lampson, M.A.5
Fukagawa, T.6
Cheeseman, I.M.7
-
136
-
-
66249092744
-
Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation
-
Wolfe, B.A., Takaki, T., Petronczki, M. & Glotzer, M. (2009) Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation. PLoS Biology, 7, e1000110.
-
(2009)
PLoS Biology
, vol.7
-
-
Wolfe, B.A.1
Takaki, T.2
Petronczki, M.3
Glotzer, M.4
-
137
-
-
3242881031
-
The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma
-
Yakushijin, Y., Hamada, M. & Yasukawa, M. (2004) The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma. Leukaemia & Lymphoma, 45, 1741-1746.
-
(2004)
Leukaemia & Lymphoma
, vol.45
, pp. 1741-1746
-
-
Yakushijin, Y.1
Hamada, M.2
Yasukawa, M.3
-
138
-
-
0035871889
-
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
-
Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R. & Naoe, T. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, 2434-2439.
-
(2001)
Blood
, vol.97
, pp. 2434-2439
-
-
Yamamoto, Y.1
Kiyoi, H.2
Nakano, Y.3
Suzuki, R.4
Kodera, Y.5
Miyawaki, S.6
Asou, N.7
Kuriyama, K.8
Yagasaki, F.9
Shimazaki, C.10
Akiyama, H.11
Saito, K.12
Nishimura, M.13
Motoji, T.14
Shinagawa, K.15
Takeshita, A.16
Saito, H.17
Ueda, R.18
Ohno, R.19
Naoe, T.20
more..
-
139
-
-
12844250703
-
Cloning and characterization of a novel human Aurora C splicing variant
-
Yan, X., Wu, Y., Li, Q., Cao, L., Liu, X., Saiyin, H. & Yu, L. (2005) Cloning and characterization of a novel human Aurora C splicing variant. Biochemical and Biophysical Research Communications, 328, 353-361.
-
(2005)
Biochemical and Biophysical Research Communications
, vol.328
, pp. 353-361
-
-
Yan, X.1
Wu, Y.2
Li, Q.3
Cao, L.4
Liu, X.5
Saiyin, H.6
Yu, L.7
-
140
-
-
1642556824
-
Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells
-
Yang, H., Ou, C.C., Feldman, R.I., Nicosia, S.V., Kruk, P.A. & Cheng, J.Q. (2004) Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Research, 64, 463-467.
-
(2004)
Cancer Research
, vol.64
, pp. 463-467
-
-
Yang, H.1
Ou, C.C.2
Feldman, R.I.3
Nicosia, S.V.4
Kruk, P.A.5
Cheng, J.Q.6
-
141
-
-
33749605644
-
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells
-
Yang, H., He, L., Kruk, P., Nicosia, S.V. & Cheng, J.Q. (2006) Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. International Journal of Cancer, 119, 2304-2312.
-
(2006)
International Journal of Cancer
, vol.119
, pp. 2304-2312
-
-
Yang, H.1
He, L.2
Kruk, P.3
Nicosia, S.V.4
Cheng, J.Q.5
-
142
-
-
34548822673
-
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
-
Yang, J., Ikezoe, T., Nishioka, C., Tasaka, T., Taniguchi, A., Kuwayama, Y., Komatsu, N., Bandobashi, K., Togitani, K., Koeffler, H.P., Taguchi, H. & Yokoyama, A. (2007) AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood, 110, 2034-2040.
-
(2007)
Blood
, vol.110
, pp. 2034-2040
-
-
Yang, J.1
Ikezoe, T.2
Nishioka, C.3
Tasaka, T.4
Taniguchi, A.5
Kuwayama, Y.6
Komatsu, N.7
Bandobashi, K.8
Togitani, K.9
Koeffler, H.P.10
Taguchi, H.11
Yokoyama, A.12
-
143
-
-
77956369534
-
Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase
-
Yang, D., Liu, H., Goga, A., Kim, S., Yuneva, M. & Bishop, J.M. (2010) Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase. Proceedings of the National Academy of Sciences of the United States of America, 107, 13836-13841.
-
(2010)
Proceedings of the National Academy of Sciences of the United States of America
, vol.107
, pp. 13836-13841
-
-
Yang, D.1
Liu, H.2
Goga, A.3
Kim, S.4
Yuneva, M.5
Bishop, J.M.6
-
144
-
-
84944606594
-
A phase I study of ENMD-2076 in patients with relapsed or refractory leukemia
-
Yee, K.W.L., Chen, H.-W.T., Brandwein, J., Chow, S., Sanfelice, D., Hedley, D., Gupta, V., Schimmer, A., Sidor, C.F., Fletcher, G., Arnott, J., Bray, M., Minden, M.D. & Schuh, A. (2010) A phase I study of ENMD-2076 in patients with relapsed or refractory leukemia. Blood (ASH Annual Meeting Abstracts), 116, 3307.
-
(2010)
Blood (ASH Annual Meeting Abstracts)
, vol.116
, pp. 3307
-
-
Yee, K.W.L.1
Chen, H.-W.2
Brandwein, J.3
Chow, S.4
Sanfelice, D.5
Hedley, D.6
Gupta, V.7
Schimmer, A.8
Sidor, C.F.9
Fletcher, G.10
Arnott, J.11
Bray, M.12
Minden, M.D.13
Schuh, A.14
-
145
-
-
14244251720
-
Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM)
-
Yokoyama, T., Goto, H., Izawa, I., Mizutani, H. & Inagaki, M. (2005) Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM). Genes Cells, 10, 127-137.
-
(2005)
Genes Cells
, vol.10
, pp. 127-137
-
-
Yokoyama, T.1
Goto, H.2
Izawa, I.3
Mizutani, H.4
Inagaki, M.5
-
146
-
-
31644438945
-
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680
-
Young, M.A., Shah, N.P., Chao, L.H., Seeliger, M., Milanov, Z.V., Biggs, III, W.H., Treiber, D.K., Patel, H.K., Zarrinkar, P.P., Lockhart, D.J., Sawyers, C.L. & Kuriyan, J. (2006) Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the Aurora kinase inhibitor VX-680. Cancer Research, 66, 1007-1014.
-
(2006)
Cancer Research
, vol.66
, pp. 1007-1014
-
-
Young, M.A.1
Shah, N.P.2
Chao, L.H.3
Seeliger, M.4
Milanov, Z.V.5
Biggs III, W.H.6
Treiber, D.K.7
Patel, H.K.8
Zarrinkar, P.P.9
Lockhart, D.J.10
Sawyers, C.L.11
Kuriyan, J.12
-
147
-
-
79958817256
-
From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma
-
Zhang, S. & Farag, S.S. (2011) From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma. Expert Opinion on Investigational Drugs, 20, 1015-1028.
-
(2011)
Expert Opinion on Investigational Drugs
, vol.20
, pp. 1015-1028
-
-
Zhang, S.1
Farag, S.S.2
-
148
-
-
57749188299
-
Targeting cancer with small molecule kinase inhibitors
-
Zhang, J., Yang, P.L. & Gray, N.S. (2009) Targeting cancer with small molecule kinase inhibitors. Nature Reviews Cancer, 9, 28-39.
-
(2009)
Nature Reviews Cancer
, vol.9
, pp. 28-39
-
-
Zhang, J.1
Yang, P.L.2
Gray, N.S.3
-
149
-
-
0031714080
-
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
-
Zhou, H., Kuang, J., Zhong, L., Kuo, W.L., Gray, J.W., Sahin, A., Brinkley, B.R. & Sen, S. (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genetics, 20, 189-193.
-
(1998)
Nature Genetics
, vol.20
, pp. 189-193
-
-
Zhou, H.1
Kuang, J.2
Zhong, L.3
Kuo, W.L.4
Gray, J.W.5
Sahin, A.6
Brinkley, B.R.7
Sen, S.8
|